Gensight will attend the American Academy of Neurology (AAN) Annual Meeting scheduled for April 25–May 1, 2020, in Toronto, Canada.

A scientific abstract has been accepted for an oral presentation.

Abstract Title:  rAAV2/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): Final Results from the RESCUE and REVERSE Phase III Clinical Trials and Experimental Data in Nonhuman Primates to Support a Bilateral Effect

  • Presenter: Mark L. Moster, MD, Neuro-Ophthalmology, Wills Eye Hospital and Professor of Neurology and Ophthalmology at Thomas Jefferson University, Philadelphia, PA, USA ; Principal Investigator in the REVERSE, RESCUE, and REFLECT trials
  • Session Name: S32 – Neuro-ophthalmology/Neuro-otology  
  • Topic: Neuro-ophthalmology/Neuro-otology 
  • Program Number: 005

Read more: